NCT05794932

Brief Summary

Post-thrombotic syndrome (PTS) is the most frequently observed chronic complication of deep vein thrombosis (DVT), with an estimated cumulative incidence of 20-50%. Endovascular venous recanalization with angioplasty and stenting of obstructive lesions is the recommended treatment option to reduce or correct the symptoms of DVT. However, its impact on the physical capacity and breathlessness of patients has not been fully demonstrated. The heterogeneous evidences of clinical improvement is probably related to the presence or absence of collateral veins developed in these patients with proximal venous obstruction (iliac or iliofemoral with or without inferior vena cava involvement), which ensure the cardiac venous return. The aim of this study is to compare changes in maximal oxygen uptake after endovascular venous recanalization in DVT patients and to evaluate the hemodynamic, respiratory and muscular improvement induced by the restoration of venous flow in the occluded segments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 3, 2023

Completed
14 days until next milestone

Study Start

First participant enrolled

April 17, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2025

Completed
Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

2.1 years

First QC Date

March 17, 2023

Last Update Submit

May 26, 2025

Conditions

Keywords

iliac veininferior vena cavaexercice tolerancecardio-pulmonary exercice testingmuscle physiological testing

Outcome Measures

Primary Outcomes (1)

  • VO2 max

    Change in VO₂ max is the maximum (max) rate (V) of oxygen (O₂) the body is able to use during exercise from baseline to 8 weeks. It is measured in liters of O2 per minute

    From baseline and 8 weeks

Secondary Outcomes (8)

  • Maximum aerobic power (in Watts)

    From baseline and 8 weeks

  • Isowork power

    From baseline and 8 weeks

  • Maximal exercise cardiac output (in litres per minute)

    From baseline and 8 weeks

  • Exercise change in Inspiratory capacity (in litres)

    From baseline and 8 weeks

  • Maximal exercise capillary volume (in millilitres)

    From baseline and 8 weeks

  • +3 more secondary outcomes

Study Arms (1)

Stress test

EXPERIMENTAL

All patients will undergo a stress test before and after venous recanalization.

Diagnostic Test: Stress test

Interventions

Stress testDIAGNOSTIC_TEST

Diagnostic Test: * Maximum effort test (CPET) on a cycloergometer * Leg muscle strength assessment * Leg muscle mass, composition and water compartments (segmental bioelectrical impedance) * Spirometry, arterial blood gaz, NO/CO transfer

Stress test

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient eligible for endovascular treatment for post-thrombotic syndrome in a chronic context (6 months after the occurrence of thrombosis, without time limit), after validation of the indication during a monthly medical-radiological PCR (St Eloi vascular medicine team and vascular radiologist performing the endovascular treatment)
  • Age \>= 18 years

You may not qualify if:

  • Contraindication to the performance of a maximal effort test on a cyclo-ergometer
  • Refusal of consent after information
  • Adult protected by law (guardianship, curatorship)
  • Pregnant or breastfeeding woman
  • Patient not affiliated to a social security system or not benefiting from such a system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Arnaud de Villeneuve - CHU de Montpellier

Montpellier, France

Location

MeSH Terms

Conditions

Postthrombotic SyndromeVenous ThrombosisIntermittent Claudication

Interventions

Exercise Test

Condition Hierarchy (Ancestors)

ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesVenous InsufficiencyPeripheral Arterial DiseasePeripheral Vascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2023

First Posted

April 3, 2023

Study Start

April 17, 2023

Primary Completion

May 15, 2025

Study Completion

May 15, 2025

Last Updated

May 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations